X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2025-03-05 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $6.99 | -20,875 | 335,346 | -6% | -$145,845 | |||||
D | 2025-03-05 | ADPT | Bobulsky Susan | Chief Commercial Officer, MRD | S - Sale+OE | $6.98 | -26,023 | 347,238 | -7% | -$181,641 | |||||
D | 2025-03-05 | ADPT | Benzeno Sharon | Chief Commercial Ofc Imm Med | S - Sale+OE | $6.98 | -44,665 | 392,723 | -10% | -$311,792 | |||||
2025-03-05 | ADPT | Piskel Kyle | CFO | S - Sale | $6.98 | -10,320 | 269,010 | -4% | -$72,072 | ||||||
2025-03-05 | ADPT | Rubinstein Julie | Pres, COO | S - Sale | $6.98 | -59,505 | 588,249 | -9% | -$415,540 | ||||||
2025-03-05 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $6.99 | -96,656 | 1,279,524 | -7% | -$675,219 | ||||||
M | 2025-03-05 | ADPT | Robins Chad M | CEO, COB | S - Sale | $7.29 | -219,569 | 2,959,249 | -7% | -$1,600,417 | |||||
D | 2025-03-06 | ADPT | Griffin Michelle Renee | Dir | S - Sale+OE | $7.94 | -15,664 | 51,685 | -23% | -$124,372 | |||||
DM | 2025-02-19 | ADPT | Robins Chad M | CEO, COB | S - Sale+OE | $8.45 | -285,187 | 2,576,701 | -10% | -$2,410,700 | |||||
DM | 2025-02-13 | ADPT | Robins Chad M | CEO, COB | S - Sale+OE | $8.47 | -470,368 | 2,576,701 | -15% | -$3,985,754 | |||||
2024-11-18 | ADPT | Piskel Kyle | CFO | S - Sale | $4.98 | -248 | 154,330 | 0% | -$1,235 | ||||||
2024-08-22 | ADPT | Taylor Stacy L | SVP, GC | S - Sale | $4.50 | -26,922 | 139,365 | -16% | -$121,079 | ||||||
2024-03-05 | ADPT | Piskel Kyle | Principal Accounting Officer | S - Sale | $3.43 | -7,727 | 123,318 | -6% | -$26,504 | ||||||
D | 2024-03-05 | ADPT | Taylor Stacy L | SVP, GC | S - Sale+OE | $3.43 | -13,381 | 166,287 | -7% | -$45,963 | |||||
D | 2024-03-05 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $3.43 | -14,700 | 256,245 | -5% | -$50,439 | |||||
D | 2024-03-05 | ADPT | Benzeno Sharon | Chief Commercial Ofc Imm Med | S - Sale+OE | $3.44 | -29,390 | 327,415 | -8% | -$100,994 | |||||
2024-03-05 | ADPT | Rubinstein Julie | Pres | S - Sale | $3.47 | -39,070 | 472,754 | -8% | -$135,764 | ||||||
2024-03-05 | ADPT | Peterson Tycho | CFO | S - Sale | $3.44 | -15,456 | 531,553 | -3% | -$53,169 | ||||||
2024-03-05 | ADPT | Robins Chad M | CEO, COB | S - Sale | $3.43 | -48,673 | 2,576,701 | -2% | -$167,007 | ||||||
D | 2024-03-05 | ADPT | Bobulsky Susan | Chief Commercial Officer, MRD | S - Sale+OE | $3.44 | -12,991 | 248,290 | -5% | -$44,629 | |||||
2023-11-16 | ADPT | Piskel Kyle | Principal Accounting Officer | S - Sale | $4.13 | -259 | 87,305 | 0% | -$1,070 | ||||||
M | 2023-08-07 | ADPT | Sood Nitin | Chief Commercial Officer, MRD | S - Sale | $6.62 | -16,202 | 214,808 | -7% | -$107,318 | |||||
D | 2023-06-20 | ADPT | Peterson Tycho | CFO | S - Sale+OE | $8.14 | -134,961 | 399,219 | -25% | -$1,098,583 | |||||
D | 2023-06-15 | ADPT | Peterson Tycho | CFO | S - Sale+OE | $8.53 | -70,000 | 399,219 | -15% | -$597,100 | |||||
2023-06-02 | ADPT | Peterson Tycho | CFO | S - Sale | $7.16 | -38,000 | 454,891 | -8% | -$272,080 | ||||||
M | 2023-04-10 | ADPT | Adams R Mark | COO | S - Sale | $8.60 | -3,125 | 175,361 | -2% | -$26,863 | |||||
2023-03-27 | ADPT | Griffin Michelle Renee | Dir | S - Sale | $8.49 | -2,341 | 20,627 | -10% | -$19,878 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |